coronary heart disease
Conditions
Interventions
clopidogrel or Ticagrelor:patients with HPR who had undergone PCI after a clopidogrel loading dose (300 mg or 600 mg). patients were randomized to either clopidogrel (300 mg LD, followed by 75 mg QD)
Sponsors
The Fourth Hospital Of Haerbin Medical University
Eligibility
Sex/Gender
All
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients aged 20 and 80 years; going to undergo PCI had been made due to non-ST segment elevation ACS between January2018 and January 2019.
Exclusion criteria
Exclusion criteria: Need to urgent PCI for ACS, as well as recent or planned medical treatment with a glycoprotein IIb/IIIa inhibitor, contraindication to the study drug, a history of transient ischemic attack, active internal or bleeding diathesis,significant hepatic dysfunction platelet count 2.5 mg/dl,
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| platelet reactivity units (PRU); | — |
Countries
China
Contacts
Public ContactEnze Jin
The Fourth Hospital Of Haerbin Medical University
Outcome results
None listed